Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for immunotherapy in multiple sclerosis

J N Whitaker1

  • 1Department of Neurology, University of Alabama at Birmingham 35294-0007.

Annals of Neurology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

Neurology·2002
Same author

Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy.

Multiple sclerosis (Houndmills, Basingstoke, England)·2002
Same author

The confluence of quality of care, cost-effectiveness, pragmatism, and medical ethics in the diagnosis of nonepileptic seizures: a provocative situation for neurology.

Archives of neurology·2001
Same author

Surgery for spinal cord compression in multiple sclerosis.

Current opinion in neurology·2001
Same author

Medical and endovascular therapy for intracranial atherosclerotic vascular disease.

Archives of neurology·2001
Same author

Triptans for migraine headache: therapeutic progress meets a heterogeneous patient response.

Archives of neurology·2001
Same journal

Five Issues of Artificial Intelligence in Science: Sailing the Ship of Theseus.

Annals of neurology·2026
Same journal

Reply to "Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm".

Annals of neurology·2026
Same journal

Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm.

Annals of neurology·2026
Same journal

Imaging of Neurovascular Compression in Thoracic Outlet Syndrome.

Annals of neurology·2026
Same journal

Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

Annals of neurology·2026
Same journal

Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease.

Annals of neurology·2026
See all related articles

Multiple sclerosis (MS) treatments have evolved from broad immunosuppression to targeted immunotherapies. Advances in immunotherapy and disease monitoring promise faster identification of effective and safe MS treatments.

Area of Science:

  • Neuroimmunology
  • Immunotherapy
  • Multiple Sclerosis Pathogenesis

Background:

  • Multiple sclerosis (MS) is presumed to be immune-mediated.
  • Previous therapies broadly targeted the immune system.

Purpose of the Study:

  • To review the evolution of MS immunotherapies.
  • To highlight the shift towards targeted immune system modulation.

Main Methods:

  • Review of general and selective immunotherapies for MS.
  • Analysis of treatments targeting antigen presentation, T-cell function, and cytokine effects.
  • Examination of therapies including glucocorticoids, immunosuppressants, plasma exchange, IV immunoglobulin, and interferon-beta.

Main Results:

Related Experiment Videos

  • Therapeutic strategies have progressed from broad immunosuppression to specific immune pathway targeting.
  • Selective approaches aim to interfere with key molecular interactions in the immune response.
  • Current trials focus on peripheral tolerance, MHC class II blockade, and immunomodulation.

    • Conclusions:

    • The combination of novel immunotherapies and sensitive monitoring is crucial for MS treatment advancement.
    • This approach facilitates quicker identification of beneficial and well-tolerated treatments for MS patients.